Envarsus XR is a prescription medication used to prevent organ rejection in adult patients receiving a kidney transplant. The cost of Envarsus XR without insurance can vary significantly depending on factors such as the pharmacy, location, and dosage.
How much does Envarsus XR cost without insurance?
The retail price for Envarsus XR can be substantial. For instance, a 30-day supply of 8 mg extended-release capsules might cost several thousand dollars. Without insurance coverage, patients often face the full list price.
Can I get financial assistance for Envarsus XR?
Pharmaceutical manufacturers sometimes offer patient assistance programs (PAPs) or co-pay cards that can help reduce the out-of-pocket cost for eligible patients. Information about these programs is typically available on the drug manufacturer's website. Additionally, non-profit organizations may offer financial aid for transplant recipients.
How does Envarsus XR work?
Envarsus XR is a calcineurin inhibitor that works by suppressing the immune system to prevent the body from rejecting a transplanted kidney [1]. It contains the active ingredient tacrolimus, which is released slowly over time.
What is the difference between Envarsus XR and other tacrolimus medications?
Envarsus XR is an extended-release formulation of tacrolimus. Traditional tacrolimus medications, such as Prograf, are immediate-release and require more frequent dosing. The extended-release formulation of Envarsus XR allows for once-daily dosing, which may offer convenience and potentially more consistent drug levels in the body [1].
When does Envarsus XR patent expire?
Drug patent information, including expiry dates, is crucial for understanding when generic versions might become available. This information can be found on specialized databases. For specific patent expiry dates related to Envarsus XR, consulting resources like DrugPatentWatch.com is recommended [2].
What are the potential side effects of Envarsus XR?
Like all medications, Envarsus XR can cause side effects. Common side effects may include diarrhea, tremors, headache, nausea, and changes in blood sugar levels. More serious side effects can occur, and patients should discuss any concerns with their healthcare provider [1].
Who manufactures Envarsus XR?
Envarsus XR is manufactured by BioStar, a subsidiary of Stellar Pharmaceuticals [3].
*
**Sources:
1. https://www.drugs.com/mtm/envarsus-xr.html
2. https://drugpatentwatch.com/
3. https://www.prnewswire.com/news-releases/nuvel-pharma-acquires-biopharma-business-from-chiesi-farmaceutici-including-envarsus-xr-and-investigational-drug-nv-3-301663317.html